Medicamen Biotech Limited

Healthcare›Healthcare›Pharmaceuticals & Biotechnology›Pharmaceuticals

Ask AI

Key metrics

Price as of 2026-07-20

Stock price
₹236.50
Market cap
321 Cr
Stock P/E
32.6
P/B
1.16
Dividend yield
0.4%

Sign in for full ratios and TTM. Learn about these metrics →

Share price

NSE closing price from historical market data.

Loading price history…

Statement tables · Consolidated

Switches quarterly, P&L, balance sheet, and cash flow. Key metrics and ratios stay on consolidated when available.

Amounts in ₹ Cr · NSE preferred when both exchanges report the same period · tap + to expand rows

Quarterly results

Quarterly · ₹ Cr · tap + rows to expand

MetricJun 2023Sept 2023Dec 2023Mar 2024Jun 2024Sept 2024Dec 2024Mar 2025Jun 2025Sept 2025Dec 2025Mar 2026
Sales42 Cr85 Cr132 Cr179 Cr43 Cr88 Cr45 Cr30 Cr43 Cr47 Cr47 Cr61 Cr
Operating expenses (approx.)35 Cr73 Cr114 Cr155 Cr39 Cr78 Cr38 Cr26 Cr38 Cr42 Cr42 Cr53 Cr
EBITDA7 Cr13 Cr18 Cr25 Cr4 Cr10 Cr7 Cr4 Cr5 Cr6 Cr5 Cr7 Cr
OPM %17.5%14.7%13.8%13.7%9.4%11.0%15.2%12.2%11.8%11.7%10.5%11.8%
Other income0.38 Cr0.93 Cr2 Cr2 Cr0.59 Cr0.88 Cr0.14 Cr5 Cr0.47 Cr0.37 Cr0.53 Cr2 Cr
Interest0.96 Cr2 Cr3 Cr4 Cr0.71 Cr2 Cr0.76 Cr0.65 Cr1 Cr0.99 Cr0.97 Cr0.38 Cr
Depreciation2 Cr4 Cr5 Cr7 Cr2 Cr4 Cr2 Cr0.48 Cr2 Cr2 Cr2 Cr2 Cr
Profit before tax5 Cr7 Cr10 Cr13 Cr2 Cr4 Cr4 Cr2 Cr2 Cr3 Cr2 Cr5 Cr
Tax %15.7%24.1%28.5%27.4%48.7%49.6%24.6%25.2%24.9%21.2%22.6%12.1%
Net profit4 Cr5 Cr7 Cr9 Cr0.80 Cr2 Cr3 Cr2 Cr2 Cr2 Cr2 Cr4 Cr
EPS (₹)₹3.12₹4.29₹5.89₹7.50₹0.63₹1.39₹2.30₹1.47₹1.18₹1.56₹1.21₹3.28

Profit & loss (annual)

Annual · last column is TTM · ₹ Cr · tap + to expand

MetricMar 2020Mar 2021Mar 2022Standalone onlyMar 2023Mar 2024Mar 2025Mar 2026TTM
Sales126 Cr113 Cr115 Cr141 Cr179 Cr163 Cr198 CrSign in for TTM
Operating expenses (approx.)106 Cr93 Cr90 Cr117 Cr157 Cr142 Cr175 CrSign in for TTM
EBITDA19 Cr19 Cr25 Cr24 Cr22 Cr20 Cr23 CrSign in for TTM
OPM %15.2%17.1%21.9%16.9%12.4%12.4%11.5%Sign in for TTM
Other income2 Cr0.75 Cr2 Cr2 Cr2 Cr6 Cr3 CrSign in for TTM
Interest0.57 Cr1 Cr1 Cr3 Cr4 Cr3 Cr3 CrSign in for TTM
Depreciation2 Cr3 Cr6 Cr6 Cr7 Cr7 Cr7 CrSign in for TTM
Profit before tax18 Cr16 Cr18 Cr17 Cr13 Cr10 Cr12 CrSign in for TTM
Tax %26.1%26.0%17.7%13.6%27.4%33.6%18.3%Sign in for TTM
Net profit13 Cr12 Cr15 Cr15 Cr9 Cr7 Cr10 CrSign in for TTM
EPS (₹)₹10.94₹9.93₹12.19₹11.82₹7.50₹5.16₹7.22Sign in for TTM
Dividend payout %——8.2%8.6%13.3%19.4%13.8%Sign in for TTM
Sign in for TTM

Trailing twelve months totals and margin rows

Balance sheet

Annual · ₹ Cr · tap + rows to expand

MetricMar 2020Mar 2021Mar 2022Standalone onlyMar 2023Mar 2024Mar 2025Mar 2026
Equity capital12 Cr12 Cr12 Cr13 Cr13 Cr13 Cr14 Cr
Reserves109 Cr121 Cr0.0000 Cr181 Cr188 Cr200 Cr262 Cr
Borrowings10 Cr17 Cr24 Cr24 Cr31 Cr30 Cr42 Cr
Other liabilities50 Cr44 Cr53 Cr61 Cr63 Cr55 Cr55 Cr
Total liabilities181 Cr194 Cr226 Cr279 Cr295 Cr297 Cr372 Cr
Fixed assets (net)33 Cr89 Cr92 Cr92 Cr91 Cr86 Cr84 Cr
CWIP40 Cr—0.0000 Cr————
Investments0.0000 Cr53 Cr2 Cr0.0000 Cr0.0000 Cr0.0000 Cr0.0000 Cr
Other assets113 Cr96 Cr126 Cr170 Cr164 Cr168 Cr262 Cr
Total assets181 Cr194 Cr226 Cr279 Cr295 Cr297 Cr372 Cr

Cash flows

Annual · ₹ Cr · tap + rows to expand · last column includes FCF

MetricMar 2020Mar 2021Mar 2022Standalone onlyMar 2023Mar 2024Mar 2025Mar 2026
Cash from operating activity——4 Cr-6 Cr-0.37 Cr-7 Cr-33 Cr
Cash from investing——-8 Cr-6 Cr-6 Cr-2 Cr-3 Cr
Cash from financing——4 Cr29 Cr-0.06 Cr-2 Cr64 Cr
Net cash flow——-0.07 Cr17 Cr-6 Cr-11 Cr28 Cr
Free cash flow (OCF − Capex)——-4 Cr-13 Cr-0.37 Cr-9 Cr-38 Cr

Ratios

Ratios as reported or derived per annual period.

MetricMar 2020Mar 2021Mar 2022Standalone onlyMar 2023Mar 2024Mar 2025Mar 2026
ROCE %12.7%11.1%159.6%8.0%6.5%5.4%4.9%
ROE %0.0%9.1%0.0%7.7%5.5%3.3%3.5%
Debtor days14513193169112——
Inventory days7728177200207250270
Days payable170171273212158——
Cash conversion cycle53-13197157161250270
Debt / equity0.080.130.160.130.150.140.15
Current ratio1.841.801.701.981.752.112.54
Net debt / EBITDA0.360.530.000.140.721.280.46

Compare with peers

Loading peers…